Evotec SE’s Seattle-based subsidiary, Just – Evotec Biologics, Inc., has been selected by the U.S. Department of Defense (DOD) to develop an accelerated monoclonal antibody (mAb) development and manufacturing solution for the DOD’s Manufacturing Optimization Program.   The multi-year program award, valued up to $39 million, will support the U.S. Government’s effort to enhance its rapid response capabilities for biologics medical countermeasures (MCMs).   Under the program, Just – Evotec Biol...